Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-20, Stock:LLY, The news for the past five days is as follows:
2021-10-13: NEWS1: FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer.
2021-10-14: NEWS1: Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology.NEWS2: Scientist behind Vertex CF drugs launches new startup with Atlas Venture.
2021-10-15: NEWS1: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS2: The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies.NEWS3: Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?.NEWS4: The FDA Is About to Make Some Major Drug Decisions. What Investors Need to Know..
2021-10-18: NEWS1: Lilly Declares Fourth-Quarter 2021 Dividend.NEWS2: PFE vs. LLY: Which Stock Should Value Investors Buy Now?.
2021-10-19: NEWS1: Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release.NEWS2: Tirzepatide results published in The Lancet show superior A1C and body weight reductions compared to insulin glargine in adults with type 2 diabetes with increased cardiovascular risk.

Answer: Rise